News
The best smart rings for women in 2024
Discover the five smart rings for women worth trying this year
Smart rings are booming, and it looks like they’re here to stay.
Although smart rings are a relatively new gadget to the wearable technology market, they have certainly gained popularity in recent years for their compact, minimalist design.
When it comes to health, these tiny yet mighty rings can serve as continuous health monitors, allowing users to track vital metrics, like heart rate, sleep patterns and activity levels, and helping them identify patterns and potential irregularities.
More importantly, the convenience of having this health data readily accessible on these devices enables women to make informed decisions about their lifestyle, promoting a more proactive, holistic approach.
To help you find the right smart ring for you, we’ve put together a list of the ones worth trying in 2024.
Oura Generation 3
The Oura ring, developed by the Finnish health technology company ŌURA, is a smart device that delivers personalised health data, insights and daily guidance.
Validated against medical gold standards and driven by continuous monitoring of individual biometrics, the Oura ring is one of the most accurate wearables available.
The ring measures blood volume pulse directly from the palmar arteries of the finger with infrared LED sensors. From that data, Oura’s algorithms calculate resting heart rate and heart rate variability, while also offering women information about their body temperature, respiratory rate and sleep stages.
Armed with these data points, users can work toward decreasing stress and increasing heart health with personalised, easy to understand reports.
The ring offers a range of reproductive health features, including Cycle Insights and integrations with the period tracking app Clue and the contraception app Natural Cycles.
Its Cycle Insights feature uses temperature deviations to track, predict and visualise women’s monthly cycle, allowing users to better understand the stages of their menstrual cycle.
ArcX
For many people, the thought of exercising in silence is unimaginable: the ArcX smart ring is designed for those who need and love, to listen to music while engaged in any one of a host of different sports.
The ring is a new type of wearable providing intuitive, hands-free control of other devices during exercise. Developed by ArcX Technology, a UK/US sports tech start-up, the device allows users to store their smartphone in a pocket or backpack while controlling playlists and other phone functions simply and easily, on the move.
While music control is still the main use case ArcX is hugely versatile. There’s an inbuilt SOS function; in the event of an accident or an emergency a quick press of the joystick and ArcX makes an outgoing call and sends an SMS with the wearer’s Google Map location.
It can also connect to any other Bluetooth enabled device such as sports cameras, wireless speakers, tablets, laptops, e-readers, TVs and AR/VR headsets.
The patented design enables the module to be swapped among different sized medical grade silicone rings or two types of strap mounts that allows the user to attach the device to a handlebar, kayak paddle, ski pole or other piece of sports equipment.
The ring boasts an impressive 20 day stand by with a battery that delivers five days of typical use from a one-hour charge time and is waterproof.
There is also a great health and safety benefit to a remote controller like ArcX, particularly for those activities that involve speed such as skiing, snowboarding, cycling and running.
Evie
The Evie ring, developed by the US company Movano Health, is the first women-focused smart ring, promising to redefine the wearable category with a unique band design, female-specific data interpretation and AI-based trend analysis.
The ring utilises highly sensitive medical-grade sensors to optimise vital sign measurement on women’s fingers, which tend to be smaller and have less blood flow than men’s, and leverages newer studies that consider women-specific factors such as hormonal changes combined with an AI engine to search for correlations across menstrual health, mood, energy, sleep and activity.
Whether it’s “We’ve noticed your mood improves when you get 1000 more steps than your average” or “Your sleep may be interrupted during this phase of your menstrual cycle due to a dip in progesterone,” these insights can help women modify their behaviours to optimise their daily routines.
Other key features include a unique Spot Check function enabling users to see their pulse rate and blood oxygen levels at any time day or night, the ability to log mood, menstrual symptoms and other information, and four days of battery life.
New features to be added include enhanced menstrual health insights and additional visualisations of menstrual data.
Femometer
The world’s first smart ring made for women’s fertility and sleep tracking, Femometer aims to help women increase their chances of natural conception with daily fertility insights and expert guidance.
Much like Oura’s innovative approach to social sleep features for health trackers, Femometer promises to deliver an innovative solution that empowers women to better understand their body and reproductive health.
The device, which caters to women seeking to conceive and those grappling with irregular menstrual cycles and sleep disruption, helps users gain insights into their cycle patterns, hormone fluctuations and sleep variations.
The ring offers continuous monitoring of basal body temperature (BBT) for precision in fertility insights, predicts fertile windows, analyses sleep stages during various menstrual cycle phases and their correlation to fertility and offers tailored suggestions for overall wellbeing.
Sleepon Go2sleep tracker
Good sleep is critical to improving brain performance, mood, and health. With research showing women are twice as likely to experience sleep problems as men, it is important to understand whether you’re getting enough quality rest every night.
Sleepon, a smart ring designed specifically to give people an in-depth understanding of their sleep trends and patterns, generates detailed sleep reports and shares useful metrics like heart rate, heart rate variability, blood oxygen and sleep stages.
The device, which replaces paper sleep diaries, revises memory bias and automatically processes and analyses data, helping women improve their sleep quality and restore their circadian rhythm.
To receive the Femtech World newsletter, sign up here.
The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.
Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.
It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.
WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.
The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.
WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.
Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.
WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.
The launch comes amid wider concern about misinformation in sexual and reproductive health.
A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.
The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.
WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.
Wellness
Women’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage
Women’s HealthX has announced its lineup of healthcare trailblazers speaking on Chronic Disease Management, alongside other specialisations including Fertility, Sexual Health, Maternity, Menopause and Cognitive Health, taking a holistic approach to women’s health.
It will bring together 750+ leaders across pharma, health systems, and innovation to address one of the most urgent and underexamined challenges in healthcare; the sex difference gap in data and evidence.
Since cardiovascular disease remains the leading cause of death among women globally, and autoimmune and neurological conditions affect women at significantly higher rates, Women’s HealthX will home in on chronic disease management with 17+ sessions spotlighting case studies and lessons learned.
The Chronic Disease Management Stage at Women’s HealthX responds directly to this gap, convening senior decision makers and innovators to explore how sex specific science, digital health, and new care models can reshape outcomes for women.
Attending pharma & healthcare organisations include:
- Tracy Sims, Executive Director, Cardiometabolic Health, Eli Lilly
- Adrian Kielhorn, Senior Director, Global Head HEOR Neurology, Alexion Pharmaceuticals
- Lauren Powell, Head of Health Equity and Clinical Innovation, Biogen
- Amy Kao, SVP, Head of Neuroscience and Immunology Research, EMD Serono
- Stella Vnook, Executive Chair and CEO, Kaida Biopharma
- Amanda Borsky, Director, Clinical Research, Northwell Health
- Lacey McIntosh, Division Chief, Oncologic and Molecular Imaging, UMass Memorial Medical Center
- Nicole Turck, Vice President Operations, Women’s Health, Corewell Health
- Mette Dyhrberg, CEO, Autoimmune Registry
- Lyn Agostinelli, Principal Consultant, Halloran Consulting Group
Sessions addressing the real gaps in women’s chronic care
The agenda features a series of high impact sessions tackling the structural and scientific gaps in women’s health:
- Improving outcomes in obesity through evidence based person centered care: Eli Lilly
- Tackling sex based health inequities by breaking down barriers and bias: Alexion Pharmaceuticals
- Close the health equity gap in women’s health by improving how autoimmune diseases are diagnosed, treated and managed: Autoimmune Registry
- How a GYN only care model is driving faster access to gynecological care: Corewell Health
- Transforming early detection in ovarian cancer: new pathways to accuracy, safety, and better outcomes: UMass Memorial Medical Center
Panel discussions include:
- Why chronic disease looks different in women and why health systems haven’t adapted: Biogen, Kaida Biopharma, EMD Serono
- How can we better engage with our customers: Northwell Health, Halloran Consulting Group
Health equity starts here. REGISTER YOUR PLACE
Why This Matters Now
Women’s HealthX positions chronic disease not just as a clinical challenge, but as a critical frontier for innovation, investment, and system redesign.
From AI powered monitoring and digital therapeutics to real world data and integrated care pathways, the stage highlights where meaningful progress is already being made and where the biggest opportunities lie.
For the FemTech ecosystem, this represents a pivotal moment: aligning technology, clinical insight, and commercial strategy to finally close the long standing data and care gaps in women’s health.
About Women’s HealthX
Women’s HealthX is where the transformation of women’s health begins at its true foundation: data, science, and evidence.
It’s the leading event dedicated to closing the sex difference data gap and accelerating breakthroughs through science driven, real world case studies.
Taking place on December 3 to 4, 2026 in Boston, USA, the exhibition will bring together more than 750 healthcare leaders, including clinicians, payers, employers, investors, and policymakers.
Seven different stages with 150+ expert speakers taking an holistic approach to women’s health. From fertility, maternity, sexual health, cognitive health, menopause and chronic disease, we address care at every stage of a woman’s life.
An AI atlas has mapped how reproductive organs age through menopause, with the ovaries, vagina and uterus changing on different timelines.
To better understand how this process affects health, researchers at the Barcelona Supercomputing Center developed what they describe as the first large-scale atlas of female reproductive system ageing, using artificial intelligence.
The team combined 1,112 tissue images from 659 samples, covering 304 women aged 20 to 70, with gene expression data from thousands of genes.
This allowed them to reconstruct how seven key reproductive organs, including the uterus, ovary, vagina, cervix, breast and fallopian tubes, age over time.
The study used the supercomputing power of MareNostrum 5 together with advanced image-recognition methods to process the data.
Using deep learning techniques, the researchers detected visible tissue changes as well as the underlying molecular processes linked to ageing in each organ.
The result was a detailed, organ-by-organ map of the reproductive system’s ageing process.
The researchers found that not all organs age in the same way or at the same speed. The ovaries and vagina showed a more gradual ageing process that begins even before menopause officially starts.
By contrast, the uterus appeared to undergo more sudden changes around the time of menopause.
Even within a single organ, different tissues aged at different rates. In the uterus, for example, the mucosa, its inner lining, and the muscular layer did not change in sync. These tissues also appeared to be particularly sensitive to the hormonal and biological shifts associated with menopause.
Marta Melé, leader of the transcriptomics and functional genomics group at BSC and director of the study, said: “Our results show that it acts as a turning point that profoundly reorganises other organs and tissues of the reproductive system, and allows us to identify the genes and molecular processes that could be behind these changes.”
Building on the finding that organs age according to different patterns, co-first author Laura Ventura said the research “paves the way for personalised medicine where treatments are tailored to a woman’s specific molecular profile and the specific tissues showing the most age-related distress.”
The study also identified molecular signals linked to reproductive ageing that can be detected in blood samples from more than 21,441 women.
These biomarkers could allow doctors to monitor the condition of reproductive organs in a non-invasive way, potentially helping to anticipate risks such as pelvic floor complications without the need for biopsies.
According to the researchers, this could lead to simpler and more accessible clinical tools for tracking women’s health over time.
Entrepreneur1 week agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News3 weeks agoSelf-employment linked to better cardiovascular health outcomes in Hispanic women
17 Comments